STOCK PURCHASE AGREEMENTStock Purchase Agreement • June 11th, 2018 • Immune Therapeutics, Inc. • Pharmaceutical preparations • Florida
This STOCK Purchase Agreement (this “Agreement”) is made and entered into effective as of the 4th day of June 2018, by and between Immune Therapeutics, Inc., a Florida corporation (“IMUN”), and Cytocom, Inc., a Delaware corporation (“Company”).
LICENSE AGREEMENTLicense Agreement • June 11th, 2018 • Immune Therapeutics, Inc. • Pharmaceutical preparations • Florida
This LICENSE AGREEMENT (the “Agreement”) is made as of May 1, 2018 (the “Effective Date”) by and between Cytocom Inc., a Delaware corporation having its principal place of business at 37 North Orange Ave Suite 607 Orlando Florida 32801 United States (“Cytocom”), and Immune Therapeutics Inc., a company registered under the laws of Florida, and having a registered office at 37 North Orange Ave Suite 607 Orlando Florida 32801 (“Licensee”). This Agreement amends and restates in its entirety the license agreement between the parties, dated September 30, 2014.
